【24h】

Impulse control disorders in Parkinson's disease in a Chinese population.

机译:中国人帕金森氏病的冲动控制障碍。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Dopamine agonists have been used as first-line treatments for patients with Parkinson's disease (PD) during its early stage, and several impulse control disorder (ICD) behaviors have been reported to be associated with their use. Objective: To investigate the association between ICD behaviors and the use of agonists in Chinese patients with PD and associated risk factors. METHODS: Self-report screening questionnaires were mailed to 400 PD patients treated with anti-parkinsonian drugs in our clinical database and their spouses (served as control group). Those who screened positive for ICD behaviors by questionnaire were further interviewed over the telephone by a movement disorder specialist to confirm the diagnosis. RESULTS: A total of 11 (3.53%) patients were diagnosed with ICD behaviors as follows: lifetime pathological gambling (1, 0.32%); subclinical or clinical hypersexuality (6, 1.92%); binge eating (1, 0.32%); dopamine dysregulation syndrome (2, 0.64%); and compulsive internet browsing (1, 0.32%). ICD behaviors were associated with an increased mean levodopa equivalent daily dosage and alcohol use (p=0.005 and p=0.002, respectively). Patients using dopamine agonists were significantly (p=0.003) more likely to be diagnosed with an ICD (6.3%) as compared to those who were not (0.6%). CONCLUSION: PD patients who took dopamine agonists were more likely to report ICD behaviors in Chinese PD.
机译:背景:多巴胺激动剂在帕金森氏病(PD)的早期阶段已被用作一线治疗药物,据报道有几种冲动控制障碍(ICD)行为与其使用有关。目的:探讨中国PD患者ICD行为与激动剂使用及相关危险因素之间的关系。方法:在我们的临床数据库及其配偶(作为对照组)中,向400例接受抗帕金森病药物治疗的PD患者寄出了自我报告筛查问卷。那些通过问卷调查对ICD行为呈阳性的人将通过运动障碍专家的电话进一步采访,以确认诊断。结果:总共11(3.53%)名患者被诊断患有ICD行为,如下:终生病理赌博(1,0.32%);亚临床或临床性欲亢进(6,1.92%);暴饮暴食(1,0.32%);多巴胺失调综合症(2,0.64%);和强迫性的互联网浏览(1,0.32%)。 ICD行为与平均左旋多巴等效日剂量和饮酒量增加有关(分别为p = 0.005和p = 0.002)。与未使用多巴胺受体激动剂的患者(0.6%)相比,使用多巴胺激动剂的患者被诊断出ICD的可能性更高(p = 0.003)(6.3%)。结论:服用多巴胺激动剂的PD患者更有可能报告中国PD的ICD行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号